173 related articles for article (PubMed ID: 30184529)
1. Lentiviral Vector-Mediated SHC3 Silencing Exacerbates Oxidative Stress Injury in Nigral Dopamine Neurons by Regulating the PI3K-AKT-FoxO Signaling Pathway in Rats with Parkinson's Disease.
Gong J; Zhang L; Zhang Q; Li X; Xia XJ; Liu YY; Yang QS
Cell Physiol Biochem; 2018; 49(3):971-984. PubMed ID: 30184529
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.
Cai L; Tu L; Li T; Yang X; Ren Y; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian J
Int Immunopharmacol; 2019 Oct; 75():105734. PubMed ID: 31301558
[TBL] [Abstract][Full Text] [Related]
4. Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K/Akt signaling pathway in parkinsonian cell model.
Zhao Y; Wang Q; Wang Y; Li J; Lu G; Liu Z
Environ Health Prev Med; 2019 Jan; 24(1):4. PubMed ID: 30611190
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NEAT1 promotes MPP+ induced injury of PC12 cells and accelerates the progression of Parkinson's disease in mice through FUS mediated inhibition of PI3K/AKT/mTOR signalling pathway.
Wang Y; Li Z; Li J; Sun C
Exp Gerontol; 2024 Jun; 191():112436. PubMed ID: 38636570
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
[TBL] [Abstract][Full Text] [Related]
7. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
Cui Q; Li X; Zhu H
Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
[TBL] [Abstract][Full Text] [Related]
8. Protective Effect of Curcumin Against Oxidative Stress-Induced Injury in Rats with Parkinson's Disease Through the Wnt/ β-Catenin Signaling Pathway.
Wang YL; Ju B; Zhang YZ; Yin HL; Liu YJ; Wang SS; Zeng ZL; Yang XP; Wang HT; Li JF
Cell Physiol Biochem; 2017; 43(6):2226-2241. PubMed ID: 29069652
[TBL] [Abstract][Full Text] [Related]
9. Taurine protects dopaminergic neurons in paraquat-induced Parkinson's disease mouse model through PI3K/Akt signaling pathways.
Wang K; Zhang B; Tian T; Zhang B; Shi G; Zhang C; Li G; Huang M
Amino Acids; 2022 Jan; 54(1):1-11. PubMed ID: 34837554
[TBL] [Abstract][Full Text] [Related]
10. GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease.
Sun Z; Sun L; Tu L
J Alzheimers Dis; 2020; 76(4):1513-1526. PubMed ID: 32651311
[TBL] [Abstract][Full Text] [Related]
11. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
Liu YY; Zhang YN; Yang QS
J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Attenuates the Cytotoxicity Induced by Amyloid-β
Hui Y; Chengyong T; Cheng L; Haixia H; Yuanda Z; Weihua Y
Neurochem Res; 2018 Feb; 43(2):297-305. PubMed ID: 29090409
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of DLGAP1-Antisense RNA 1 Alleviates Vascular Endothelial Cell Injury Via Activation of the Phosphoinositide 3-kinase/Akt Pathway Results from an Acute Limb Ischemia Rat Model.
Shen GH; Song Y; Yao Y; Sun QF; Jing B; Wu J; Li SY; Liu SQ; Li HC; Yuan C; Liu GY; Li JB; Liu XY; Wang HY
Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):98-107. PubMed ID: 31744785
[TBL] [Abstract][Full Text] [Related]
14. Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease.
Yang PH; Zhu JX; Huang YD; Zhang XY; Lei P; Bush AI; Xiang Q; Su ZJ; Zhang QH
Neurodegener Dis; 2016; 16(5-6):357-69. PubMed ID: 27228974
[TBL] [Abstract][Full Text] [Related]
15. Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway.
Li L; Zhou Y; Li Y; Wang L; Sun L; Zhou L; Arai H; Qi Y; Xu Y
Biomed Pharmacother; 2017 May; 89():233-244. PubMed ID: 28231545
[TBL] [Abstract][Full Text] [Related]
16. Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress.
Uranga RM; Katz S; Salvador GA
J Biol Chem; 2013 Jul; 288(27):19773-84. PubMed ID: 23687303
[TBL] [Abstract][Full Text] [Related]
17. The Protective Effect of Aspirin Eugenol Ester on Oxidative Stress to PC12 Cells Stimulated with H
Zhang ZD; Yang YJ; Liu XW; Qin Z; Li SH; Bai LX; Li JY
Oxid Med Cell Longev; 2021; 2021():5527475. PubMed ID: 34257805
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning.
Zhang SB; Liu TJ; Pu GH; Li BY; Gao XZ; Han XL
Cell Physiol Biochem; 2018; 46(4):1455-1470. PubMed ID: 29689553
[TBL] [Abstract][Full Text] [Related]
20. Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Yue Y; Qiao B; Jiang X
Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):32-36. PubMed ID: 32359380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
